Cargando…

The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Neeraj, Kumar, Sanjeev, Kumar, Abhyuday, Bhushan, Divendu, Kumar, Amarjeet, Kumar, Ajeet, Singh, Veena, Singh, Prabhat K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645816/
https://www.ncbi.nlm.nih.gov/pubmed/34916742
http://dx.doi.org/10.5005/jp-journals-10071-24000
_version_ 1784610388213497856
author Kumar, Neeraj
Kumar, Sanjeev
Kumar, Abhyuday
Bhushan, Divendu
Kumar, Amarjeet
Kumar, Ajeet
Singh, Veena
Singh, Prabhat K
author_facet Kumar, Neeraj
Kumar, Sanjeev
Kumar, Abhyuday
Bhushan, Divendu
Kumar, Amarjeet
Kumar, Ajeet
Singh, Veena
Singh, Prabhat K
author_sort Kumar, Neeraj
collection PubMed
description BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls. AIMS AND OBJECTIVE: Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity. MATERIALS AND METHODS: We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid–femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors. RESULTS: Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, p <0.0001) and severe (1416 ± 253.9 cm/second, p <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup p <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness. CONCLUSION: This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19. HOW TO CITE THIS ARTICLE: Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, et al. The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113–1119.
format Online
Article
Text
id pubmed-8645816
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-86458162021-12-15 The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness Kumar, Neeraj Kumar, Sanjeev Kumar, Abhyuday Bhushan, Divendu Kumar, Amarjeet Kumar, Ajeet Singh, Veena Singh, Prabhat K Indian J Crit Care Med Original Article BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects the cardiovascular system at many levels. It initially infects endothelial cells, inducing marked endothelial damage and inflammation. However, there was no empirical evidence of functional compromise of arterial walls. AIMS AND OBJECTIVE: Our primary objective was to study functional arterial damage in coronavirus disease 2019 (COVID-19) and establish the noninvasive measurement of arterial stiffness as an independent marker of disease severity. MATERIALS AND METHODS: We recorded the arterial stiffness of 23 mild, 21 moderate, and 20 severe COVID-19 patients grouped on the latest National Institute of Health (NIH) severity criteria. We observed arterial stiffness of COVID-19 patients with standard parameters like noninvasive estimated carotid–femoral pulse wave velocity (cfPWV), age-normalized increase in cfPWV (ANI_cfPWV), age-normalized increase in aortic augmentation pressure (ANI_AugP), and heart rate-normalized augmentation index (HRN_ AIx). All the parameters were also corrected for statistically significant confounding factors. RESULTS: Moderate and severe COVID-19 patients have extremely significantly elevated arterial stiffness than mild patients. In mild patients, cfPWV (829.1 ± 139.2 cm/second) was significantly lower than both moderate (1067 ± 152.5 cm/second, p <0.0001) and severe (1416 ± 253.9 cm/second, p <0.0001) patients. ANI_cfPWV in moderate and severe patients was significantly higher than mild patients (mild: 101.2 ± 126.1 cm/second; moderate: 279 ± 114.4 cm/second; severe: 580.1 ± 216.4 cm/second; intergroup p <0.0001). The results even after correction for significant confounding factors did not show any considerable change in the increasing trend of arterial stiffness. CONCLUSION: This study establishes the functional deterioration of arteries in proportion to the severity of COVID-19. HOW TO CITE THIS ARTICLE: Kumar N, Kumar S, Kumar A, Bhushan D, Kumar A, Kumar A, et al. The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness. Indian J Crit Care Med 2021;25(10):1113–1119. Jaypee Brothers Medical Publishers 2021-10 /pmc/articles/PMC8645816/ /pubmed/34916742 http://dx.doi.org/10.5005/jp-journals-10071-24000 Text en Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd. https://creativecommons.org/licenses/by-nc/4.0/© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Article
Kumar, Neeraj
Kumar, Sanjeev
Kumar, Abhyuday
Bhushan, Divendu
Kumar, Amarjeet
Kumar, Ajeet
Singh, Veena
Singh, Prabhat K
The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
title The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
title_full The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
title_fullStr The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
title_full_unstemmed The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
title_short The COSEVAST Study Outcome: Evidence of COVID-19 Severity Proportionate to Surge in Arterial Stiffness
title_sort cosevast study outcome: evidence of covid-19 severity proportionate to surge in arterial stiffness
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645816/
https://www.ncbi.nlm.nih.gov/pubmed/34916742
http://dx.doi.org/10.5005/jp-journals-10071-24000
work_keys_str_mv AT kumarneeraj thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarsanjeev thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarabhyuday thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT bhushandivendu thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumaramarjeet thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarajeet thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT singhveena thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT singhprabhatk thecosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarneeraj cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarsanjeev cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarabhyuday cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT bhushandivendu cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumaramarjeet cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT kumarajeet cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT singhveena cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness
AT singhprabhatk cosevaststudyoutcomeevidenceofcovid19severityproportionatetosurgeinarterialstiffness